SPARC Intraday Analysis...

SPARC Share Price

Open 340.00 Change Price %
High 372.80 1 Day 34.45 10.28
Low 333.50 1 Week 9.60 2.67
Close 369.55 1 Month 60.55 19.60
Volume 1281558 1 Year 0.05 0.01
52 Week High 388.60
52 Week Low 272.00
SPARC Important Levels
Resistance 2 405.98
Resistance 1 390.97
Pivot 358.62
Support 1 348.13
Support 2 333.12
NSE INDIA Most Active Stocks
JPASSOCIAT 23.90 4.14%
SUZLON 17.50 0.57%
SINTEX 33.95 6.93%
TATAGLOBAL 193.85 8.45%
HDIL 62.60 -0.71%
BANKBARODA 147.15 3.44%
UNITECH 8.05 1.90%
JPINFRATEC 17.95 4.97%
RCOM 23.35 -3.11%
GMRINFRA 16.50 2.80%
More..
NSE INDIA Top Gainers Stocks
SHREYAS 365.75 20.00%
MURUDCERA 45.45 17.29%
KIRLOSIND 1651.35 17.18%
NAKODA 0.35 16.67%
RAMANEWS 27.15 14.80%
GODFRYPHLP 1041.80 14.51%
CYBERTECH 57.00 13.89%
THANGAMAYL 368.25 13.41%
RBL 1323.15 12.83%
PRAKASH 115.75 12.05%
More..
NSE INDIA Top Losers Stocks
RELIGARE 69.60 -15.79%
PRAKASHSTL 0.40 -11.11%
AARVEEDEN 29.40 -9.95%
SANGHVIMOV 141.85 -8.34%
BLUEBLENDS 32.35 -7.97%
PBAINFRA 15.65 -7.94%
JPOLYINVST 59.95 -7.84%
RESPONIND 47.90 -7.35%
PARSVNATH 20.00 -6.76%
SIGNET 8.40 -6.15%
More..

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 5
As on 16th Aug 2017 SPARC Share Price closed @ 369.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 321.29 & Strong Buy for SHORT-TERM with Stoploss of 321.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for August
1st Target up-side 425.59
2nd Target up-side 458.43
3rd Target up-side 491.26
1st Target down-side 331.91
2nd Target down-side 299.07
3rd Target down-side 266.24
SPARC Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 59.86 Sideways
MFI (14) MFI is 64.67 Sideways
CCI (20) CCI is 23.26 Sideways
WILLIAM %R (14) William %R is -29.95 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 382.56
10 Day Avg Volume Traded 150.11 % More then 10 Day Average Volume
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.sunpharma.in
SPARC Address
SPARC
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
India
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.